← Leaderboards
Deliang Cao
Southern Illinois University Sch Of Med
$678,013
Attributed
$678,013
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $337.1K · FY2007–09$500K$375K$250K$125K$0
'07
'08
'09
Funding mix
By agency
NIH$678,013 · 2
By mechanism
R21$678,013 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Gene Targeting”
- David Heimbrook · Leidos Biomedical Research, Inc.$205,122,388
- Richard A Gibbs · Baylor College Of Medicine$161,086,449
- Barton F Haynes · Duke University$98,448,044
- Andrzej Joachimiak Joachimiak · University Of Chicago$94,692,413
- Eric Martin McDade · Washington University$94,632,845
- Stephen S. Rich · University Of Alabama At Birmingham$84,483,911
Research focus
Gene TargetingCytotoxicMalignant NeoplasmsCessation Of LifeProteinsDiagnosisEarly DiagnosisToxic EffectTissuesMetabolismTumor TissueUnited StatesAldehyde ReductaseCancer EtiologyResponseAlcoholsTetracyclinesGene TransferCellsFuture2-ButenalAntitumor AgentColonAccounting
Grant awards (4)
Role of Aldose Reductase-Like-1 in Colon Tumorigenesis$196,425
R21 · FY2009 · CA · contact PI
Aldose Reductase-Like-1, a Novel Hepatocellular Carcinoma Drug Resistant Protein$173,400
R21 · FY2008 · CA · contact PI
Role of Aldose Reductase-Like-1 in Colon Tumorigenesis$163,688
R21 · FY2008 · CA · contact PI
Aldose Reductase-Like-1, a Novel Hepatocellular Carcinoma Drug Resistant Protein$144,500
R21 · FY2007 · CA · contact PI